Radiation and immunotherapy join forces in new cancer trial
NCT ID NCT07277777
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a special type of radiation (called 125I seed brachytherapy) to standard immunotherapy can help shrink tumors and keep them from growing back. The trial will include 90 adults with various cancers that have come back or spread. Half will get the combination treatment, and half will get immunotherapy alone. The goal is to see if the radiation makes the immune system work better against the cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The 960th Hospital of People's Liberation Army (PLA)
Jinan, Shandong, 250031, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo aims to shrink Hard-to-Treat tumors
- Cancer gene study aims to unlock prognosis secrets
- Massive 10-Year health check: what happens when chronic diseases collide?
- X-rays may damage red blood cells: study seeks safe limits
- New scan could sharpen cancer detection
- Smart scans may boost power of radioactive seeds against cancer